$GALE Headlines Top longs and shorts to watch 12:18 p.m.

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$GALE Headlines

Top longs and shorts to watch 12:18 p.m. March 6, 2012 - The Trading Deck

Prognosticating 2014: Athersys Shares Will Continue To Climb 2:51 p.m. Jan. 7, 2014 - Seeking Alpha
Galena Biopharma rises as first patient enrolled in FBP study 8:10 a.m. Jan. 7, 2014 - Seeking Alpha
Galena Enrolls First Patient in GALE-301 Cancer Immunotherapy Phase 2 Clinical Trial in Ovarian Cancer 6:10 a.m. Jan. 7, 2014 - benzinga.com
Biotech Stocks Under $10 With Huge Upside Potential for 2014 7:39 a.m. Jan. 3, 2014 - 247WallSt.com
Galena Biopharma rallies, SA bull upbeat for 2014 3:02 p.m. Dec. 31, 2013 - Seeking Alpha
The Young And Restless Portfolio Update: Heading Into 2014 After A Fabulous 2013 10:07 a.m. Dec. 31, 2013 - Seeking Alpha
Galena Biopharma Inc. (GALE) Shares March Higher, Can It Continue? - Tale of the Tape 8:41 a.m. Dec. 31, 2013 - Zacks.com
Team Alpha Portfolio Updates: 2014 Could Be The Year Of The Dividend Champs 9:00 a.m. Dec. 30, 2013 - Seeking Alpha
Ten Top Stocks Trading Under $10 to Buy for Big 2014 Gains 6:12 a.m. Dec. 27, 2013 - 247WallSt.com
Team Alpha Portfolios For Retirement: When Is Enough, Enough? 6:41 a.m. Dec. 25, 2013 - Seeking Alpha
Investing In A Rising Interest Rate Environment 11:55 a.m. Dec. 23, 2013 - Seeking Alpha
Will Galena's Post-Holiday Charm Continue? 11:51 a.m. Dec. 19, 2013 - Seeking Alpha
Trade-Ideas: Galena Biopharma (GALE) Is Today's "Perilous Reversal" Stock 10:12 a.m. Dec. 12, 2013 - TheStreet.com
3 Breast Cancer Drugs That Could Boost Your Portfolio 4:45 p.m. Dec. 11, 2013 - Seeking Alpha
Today's Dead Cat Bounce Stock: Galena Biopharma (GALE) 3:01 p.m. Dec. 11, 2013 - TheStreet.com
Can The Uptrend Continue for Galena Biopharma Inc. (GALE)? - Tale of the Tape 7:15 a.m. Dec. 10, 2013 - Zacks.com
4 Reasons Why Galena Biopharma Is Headed Higher 1:05 p.m. Dec. 4, 2013 - Wall St. Cheat Sheet
Perilous Reversal Stock: Galena Biopharma (GALE) 11:40 a.m. Dec. 3, 2013 - TheStreet.com
Galena rallies, article calls pipeline "rich" 11:31 a.m. Dec. 2, 2013 - Seeking Alpha
Biotech Stocks Partying Like It's 1999 7:00 a.m. Dec. 2, 2013 - TheStreet.com


Morning Buzzers: Facebook Inc, Galena Biopharma Inc, Plug Power Inc, Cell Therapeutics Inc, Advanced Micro Devices 10:50 a.m. Jan. 7, 2014 - ACCESSWIRE
Galena Biopharma Enrolls First Patient in GALE-301 (Folate Binding Protein (FBP)) Cancer Immunotherapy Phase 2 Clinical Trial in Ovarian Cancer 7:05 a.m. Jan. 7, 2014 - GlobeNewswire
Special Stocks Analysis: ImmunoCellular Therapeutics, Vodafone Group, BlackBerry Ltd, Galena Biopharma Inc 10:04 a.m. Dec. 24, 2013 - ACCESSWIRE
Technical Research on Equities: Ariad Pharma, MannKind, Galena Biopharma, and Novavax 8:00 a.m. Dec. 23, 2013 - PR Newswire
Clinical Studies Updates, and Stock Price Movements - Research Report on Merck, Select Medical Holdings, Galena Biopharma, Dendreon, and Echo Therapeutics 8:00 a.m. Dec. 16, 2013 - PR Newswire
TrendingWallStreet.com Begins Volume Coverage on FB, TC, OCZ, and GALE 12:21 a.m. Dec. 5, 2013 - ACCESSWIRE
Breakfast News: Hewlett-Packard Company, Alpha Natural Resources, Yahoo! Inc, Galena Biopharma 8:51 a.m. Dec. 4, 2013 - ACCESSWIRE
Corporate News, Acquisitions: Herbalife Ltd, 3D Systems Corporation, Federal National Mortgage Association, Galena Biopharma Inc, Oncomed Pharmaceuticals 8:44 a.m. Dec. 4, 2013 - PR Newswire
Galena Biopharma to Present at the Oppenheimer 24th Annual Healthcare Conference 7:05 a.m. Dec. 4, 2013 - GlobeNewswire
Healthcare Sector Announce Awards, Conference Participation, Partnerships, and Closure of Public Offering - Research Report on Regeneron, Alnylam, Galena Biopharma, Amedisys, and Aeterna Zentaris 8:00 a.m. Dec. 3, 2013 - PR Newswire
TrendingWallStreet.com Begins Volume Coverage on MYGN, FNMA, ABX, and GALE 12:26 a.m. Dec. 3, 2013 - ACCESSWIRE
Pre-Market Breakdown: Galena Biopharma Inc., Novavax Inc., Ariad Pharma Inc., and MannKind Corp. 8:00 a.m. Nov. 27, 2013 - PR Newswire
Galena Biopharma to Present at the 25th Annual Piper Jaffray Healthcare Conference 7:05 a.m. Nov. 26, 2013 - GlobeNewswire
HIMX, GALE, INTC and NVGN added to NASDAQ Active Stock Watch List at GSR 10:16 a.m. Nov. 25, 2013 - ACCESSWIRE
Settlement Agreement, Presentation of Trial Results, and Stock Price Update - Research Report on Johnson & Johnson, Mettler-Toledo, Galena Biopharma, Dendreon, and Amedisys 8:00 a.m. Nov. 25, 2013 - PR Newswire
Quarterly Reports and Events - Research Report on Mettler-Toledo, Galena Biopharma, Achillion, Wright Medical, and OXiGENE 8:00 a.m. Nov. 15, 2013 - PR Newswire
ZLCS, CLRX, DSCO and GALE added to NASDAQ Active Stock Watch List at GSR 10:19 a.m. Nov. 11, 2013 - ACCESSWIRE
Galena Biopharma Announces Initial Results From the Folate Binding Protein Vaccine Phase 1 Trial at the Society for Immunotherapy of Cancer Conference 7:05 a.m. Nov. 11, 2013 - GlobeNewswire
Galena Biopharma Reports Third Quarter 2013 Results 4:35 p.m. Nov. 6, 2013 - GlobeNewswire
Closing of Over-Allotment Options, Receiving Orphan Drug Designations, Release of Clinical Data, and Obtaining Important Patents - Research Report on Galena, Zalicus, Infinity, Stemline and Insmed 8:00 a.m. Nov. 5, 2013 - PR Newswire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Quanta Services Reports Record Q3 2026 Earnings

Updated Category News Views 0

Quanta Services Smashes Q3 2026 Expectations If you're a stakeholder in Quanta Services, you'd probably be dancing in the aisles right now. This company just posted off-the-charts numbers for the third quarter of 2026. We're talking revenues of $12 billion—a staggering leap from $7.63 billion the same quarter last year. Explosive Earnings and Strong Backlog The star of...

Continue Reading
Faith on Trial: La Luz del Mundo Faces Court Ruling

Updated Category News Views 63

A Legal Battle Over Religious Freedom When folks start talking about religion intertwining with law, things get real tricky, real quick. The La Luz del Mundo church is knee-deep in such a legal tussle. On October 28, 2026, the United States District Court for the Southern District of New York gave a nod to the prosecution, denying the church's pretrial motions. What we've...

Continue Reading
2026 Data Integration Stars: User Sentiments Revealed

Updated Category News Views 65

Users Crown Data Integration Champions Right out of the gate, let's make one thing clear: when you're picking a data integration solution, you're essentially hitching your wagon to a vendor. This partnership, like any, can make or break your operations, and no one knows this better than the folks who've been through the trenches. Enter Infotech's 2026 Emotional Footprint...

Continue Reading
Banco Macro S.A. Plans $160B Share Buyback Initiative

Updated Category News Views 24

Tapping into Share Buybacks in a Tumultuous Market Out of nowhere, Banco Macro S.A. has decided to whip up a share buyback program, a lifeline for their current market value. Let me tell you, the market's more volatile than a caffeinated squirrel these days, hitting the financial scenery harder than a hammer on a glass table. So, Banco Macro's taken a deep breath and...

Continue Reading
Smartpress: Adobe & Canva Shape Print Design World

Updated Category News Views 115

Adobe's Stranglehold on Professional Design Over at Smartpress, they've pulled the curtain back on just how heavily Adobe Creative Suite weighs in on the print design sector. The company's recent analysis shines a light on the staggering 66% dominance of Adobe's InDesign and Illustrator in file submissions. That's a hefty portion influencing both the quality and financial...

Continue Reading
Atlantic Blvd Apartments: A Game-Changer for Housing

Updated Category News Views 31

A Bold Move for Attainable Housing Amidst the hustle and bustle of Sterling, Virginia, a new player has hit the scene: Atlantic Blvd Apartments. A property designed solely for attainable housing, this development is a showcase of what can be accomplished when local government and private developers team up with a shared vision. It feels like a breath of fresh air in a...

Continue Reading
Data Breach at Lumara Bio: Privacy Lawsuits Loom

Updated Category News Views 206

Another Day, Another Data Breach It seems like you can’t throw a stone without hitting a data breach these days—and this time, it’s Lumara Bio USA’s turn under the spotlight. The Princeton-based oncology therapeutics outfit, part of Germany’s ITM Isotope Technologies, spilled some beans it never meant to. We're talking some pretty sensitive stuff here, folks....

Continue Reading
Clip Expands Horizons with Pulpos Acquisition, New Board Member

Updated Category News Views 128

Clip's Strategic Move with Pulpos Clip just laid down a serious marker in the digital payment world by snagging Pulpos, a firm that’s got its claws deep into AI-driven business management software. This move isn't just some fancy headline. It's a real, grounded step in expanding Clip's ecosystem to bolster the backbone of Mexico's economy: small and medium-sized...

Continue Reading
Infection Control Market Set for Explosive Growth by 2031

Updated Category News Views 101

Untangling the Surge in Infection Control Demand Lately, it's like every healthcare joint worldwide is scrambling for better infection control. We're talking about a market poised to jump from a whopping USD 58.5 billion in 2026 to USD 80.2 billion by 2031—a tidy 37% uptick. That change, brewing at a 6.5% CAGR, speaks volumes about where the industry's heading. What's...

Continue Reading
Genefluence Launches Rapid UTI PCR Test at Chelsea Hospital

Updated Category News Views 76

There's a fresh breeze blowing through the dusty corridors of healthcare, shaking things up for the better. You see, Genefluence, the brainchild of Professor Chris Toumazou, isn't just throwing a bunch of tech jargon around—it's setting the stage for a much-needed shake-up in how we handle urinary tract infections (UTIs) and, believe me, it couldn’t have come sooner....

Continue Reading

Top 5 Most Recently Viewed Articles

Semler Scientific Faces Class Action Lawsuit Amid Stock Drops

Updated Category News Views 353

Semler Scientific Under Legal Scrutiny Pomerantz LLP has announced that a class action lawsuit has been initiated against Semler Scientific, Inc. (NASDAQ: SMLR). This legal action is directed towards investors who believe they have suffered losses related to their investments in Semler. If you identify with this situation, it's crucial to reach out to a legal...

Continue Reading
Investors of Ford Motor Company Urged to Act on Lead Plaintiff Deadline

Updated Category News Views 188

Crucial Legal Update for Ford Motor Company Investors When it comes to safeguarding your investments, timing is everything. If you're an investor in Ford Motor Company (NYSE: F), it's important to be aware of an upcoming lead plaintiff deadline that's critical for taking action. A pending class action lawsuit highlights serious misrepresentations and operational issues...

Continue Reading
Procter & Gamble Positioned for Long-Term Success Amid Challenges

Updated Category News Views 383

The Procter & Gamble Company Performance Overview The Procter & Gamble Company (NYSE: PG) has demonstrated remarkable resilience, surpassing forecasts for both organic sales and margins during the recent quarter. Despite the challenging economic landscape, the company's commitment to maintaining its full-year revenue and earnings per share (EPS) guidance remains...

Continue Reading
Eos Energy Welcomes Joseph Nigro to Its Board of Directors

Updated Category News Views 252

Joseph Nigro Joins Eos Energy Enterprises Board EDISON, N.J. — Eos Energy Enterprises, Inc. (NASDAQ: EOSE), a key player in energy storage solutions, recently announced the appointment of Joseph Nigro to its Board of Directors, effective immediately. Bringing a wealth of experience from the energy sector, Nigro's role is poised to be pivotal as the company continues its...

Continue Reading
Plug Power Faces Challenges Post Q3 Earnings Report

Updated Category News Views 168

Overview of Recent Performance Plug Power Inc (NASDAQ: PLUG) has been facing significant trading challenges recently as the market responds to a mixed third-quarter earnings report. The report revealed unmet revenue expectations and evolved investor sentiment, leading to a dip in share prices. Investors are vigilantly observing the company's financial trajectory and...

Continue Reading